Results 11 to 20 of about 60,641 (297)

Assessment of Serum Prolactin Level in Patients Women with Rheumatoid Arthritis

open access: yesمجلة بغداد للعلوم, 2015
The prolactin hormone played role in the many autoimmune disorders. To determine the importance of high levels of prolactin in triggering rheumatoid arthritis, thirty patient's women with hyperprolactinemia aged (20-45) years old have been investigated ...
Baghdad Science Journal
doaj   +1 more source

Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management [PDF]

open access: yes, 2018
Oral signs are frequently the first manifestation of autoimmune diseases. For this reason, dentists play an important role in the detection of emerging autoimmune pathologies.
Bossù, Maurizio   +5 more
core   +2 more sources

Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children

open access: yesThe Turkish Journal of Pediatrics, 1999
The frequency of antinuclear antibodies (ANA) and rheumatoid factor (RF) was investigated in 118 apparently healthy children (56 male, 62 female). The mean age was 9.8 ± 2.3 years.
Özgür Kasapçopur   +5 more
doaj   +1 more source

Understanding antinuclear antibodies

open access: yesThe Journal of the American Osteopathic Association, 1991
The American College of Rheumatology (formerly the American Rheumatism Association) diagnostic criteria for connective tissue disorders frequently include positive antinuclear antibody (ANA) assays. Proper interpretation of these tests requires an understanding of the principles governing ANA assays.
R M, Pertusi, B R, Rubin
openaire   +2 more sources

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus [PDF]

open access: yes, 2015
Introduction ES-62, a phosphorylcholine (PC)-containing immunomodulator secreted by the parasitic worm Acanthocheilonema viteae, protects against nephritis in the MRL/Lpr mouse model of systemic lupus erythematosus (SLE).
Harnett, M. M.   +4 more
core   +1 more source

Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)

open access: yesНаучно-практическая ревматология, 2023
The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis ...
T. A. Panafidina   +4 more
doaj   +1 more source

Nuclear Antigens and Auto/Alloantibody Responses: Friend or Foe in Transplant Immunology

open access: yesClinical and Developmental Immunology, 2013
In addition to cellular immune responses, humoral immune responses, mediated by natural antibodies, autoantibodies, and alloantibodies, have increasingly been recognized as causes of organ transplant rejection.
Toshiaki Nakano   +2 more
doaj   +1 more source

Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System. [PDF]

open access: yes, 2015
ObjectiveIn 2013, the American College of Rheumatology (ACR) participated in the Choosing Wisely campaign and devised a recommendation to avoid testing antinuclear antibody (ANA) subserologies without a positive ANA and clinical suspicion of disease. The
Davis, Lisa Anne   +7 more
core   +2 more sources

Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients [PDF]

open access: yes, 2020
Background: Systemic sclerosis (SSc) and primary biliary cholangitis (PBC) are autoimmune diseases that may occur concomitantly and are both strongly associated with disease-specific autoantibodies.
Bonroy, Carolien   +6 more
core   +1 more source

Comprehensive Exploration of Antinuclear Antibodies (ANAs): Unveiling Clinical Significance, Associations with Cancer, and the Nuances of Differential Diagnosis in Positive ANA Patients. [PDF]

open access: goldDiagnostics (Basel)
Kraev K   +10 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy